180 related articles for article (PubMed ID: 1097571)
1. C1q deviation test for the detection of immune complexes, aggregates of IgG, and bacterial products in human serum.
Sobel AT; Bokisch VA; Müller-Eberhard HJ
J Exp Med; 1975 Jul; 142(1):139-50. PubMed ID: 1097571
[TBL] [Abstract][Full Text] [Related]
2. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.
Nydegger UE; Lambert PH; Gerber H; Miescher PA
J Clin Invest; 1974 Aug; 54(2):297-309. PubMed ID: 4847246
[TBL] [Abstract][Full Text] [Related]
3. [Detection of circulating immune complexes by the C1q complement fraction deviation test. 1st application in the study of human glomerulopathies].
Sobel A; Gabay Y; Lagrue G
Nouv Presse Med; 1976 Jun; 5(23):1465-9. PubMed ID: 132639
[TBL] [Abstract][Full Text] [Related]
4. Detection of IgG aggregates or immune complexes using solid-phase C1q and protein A-rich Staphylococcus aureus as an indicator system.
Farrell C; Sogaard H; Svehag SE
Scand J Immunol; 1975; 4(7):673-80. PubMed ID: 1198069
[TBL] [Abstract][Full Text] [Related]
5. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.
Hardin JA; Walker LC; Steere AC; Trumble TC; Tung KS; Williams RC; Ruddy S; Malawista SE
J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566
[TBL] [Abstract][Full Text] [Related]
6. Solid-phase Clq-binding fluorescence immunoassay for detection of circulating immune complexes.
Collins MM; Casavant CH; Stites DP
J Clin Microbiol; 1982 Mar; 15(3):456-64. PubMed ID: 6804486
[TBL] [Abstract][Full Text] [Related]
7. Detection of immune complexes. The use of radioimmunoassays with Clq and monoclonal rheumatoid factor.
Gabriel A; Agnello V
J Clin Invest; 1977 May; 59(5):990-1001. PubMed ID: 323292
[TBL] [Abstract][Full Text] [Related]
8. Critical aspects of the 125I-C1q binding assay for detecting immune complexes in tumor patients.
Krieger G; Bause I; Kneba M; Kehl A; Nagel GA
J Clin Lab Immunol; 1984 Jun; 14(2):87-92. PubMed ID: 6611419
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of interaction between complement-fixing antibody/dsDNA immune complexes and erythrocytes. In vitro studies and potential general applications to clinical immune complex testing.
Taylor RP; Horgan C; Hooper M; Burge J
J Clin Invest; 1985 Jan; 75(1):102-11. PubMed ID: 3917462
[TBL] [Abstract][Full Text] [Related]
10. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
Medof ME
J Lab Clin Med; 1982 May; 99(5):678-92. PubMed ID: 6978370
[TBL] [Abstract][Full Text] [Related]
11. A Clq immunosorbent assay compared with thin-layer gel filtration for measuring IgG aggregates.
Ahlstedt S; Hanson LA; Wadsworth C
Scand J Immunol; 1976; 5(3):293-8. PubMed ID: 1273518
[TBL] [Abstract][Full Text] [Related]
12. A solid-phase radioimmunoassay for C1q-binding immune complexes. I. Delta IgG as indicator molecule.
Svehag SE
Scand J Immunol; 1975; 4(7):687-97. PubMed ID: 1198070
[TBL] [Abstract][Full Text] [Related]
13. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro.
Daha MR; Miltenburg AM; Hiemstra PS; Klar-Mohamad N; Van Es LA; Van Hinsbergh VW
Eur J Immunol; 1988 May; 18(5):783-7. PubMed ID: 3259929
[TBL] [Abstract][Full Text] [Related]
14. The detection of complement binding immune complexes by means of 51Cr-labelled indicator cells.
Varga A; Kasper M; Stosiek P
Allerg Immunol (Leipz); 1986; 32(3):205-14. PubMed ID: 2947445
[TBL] [Abstract][Full Text] [Related]
15. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
[TBL] [Abstract][Full Text] [Related]
16. Circulating immune complexes in the serum of diabetes mellitus in childhood by a modified 125I-C1q binding test.
Nagaoka K; Chinen Y; Takegami T; Nabeya N; Sakurami T; Imura H; Kuno S; Tasaka K; Hamajima Y
Endocrinol Jpn; 1979 Oct; 26(5):527-32. PubMed ID: 316767
[TBL] [Abstract][Full Text] [Related]
17. [A method of isolating C1q from human serum and its use in the solid-phase immunoenzyme determination of immune complexes].
Belozerov AP
Lab Delo; 1989; (3):24-6. PubMed ID: 2469833
[TBL] [Abstract][Full Text] [Related]
18. A new capillary tube agglutination-inhibition test for the detection of circulating immune complexes containing endogenously bound C1q.
Reckel RP; Harris J; Botsko E; Pollack W
Immunol Lett; 1981 Jun; 3(2):107-13. PubMed ID: 7262915
[TBL] [Abstract][Full Text] [Related]
19. The C1q binding test for soluble immune complexes: clinical correlations obtained in patients with cancer.
Rossen RD; Reisberg MA; Hersh EM; Gutterman JU
J Natl Cancer Inst; 1977 May; 58(5):1205-15. PubMed ID: 323505
[TBL] [Abstract][Full Text] [Related]
20. [Detection of circulating immune complexes by three techniques using polyethylene glycol (author's transl)].
Digeon M; Bach JF
Nouv Presse Med; 1977 Dec; 6(43):4031-7. PubMed ID: 600749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
